Because VEGFC expression can predict outcome and prognosis in both pediatric and adult patients with AML, higher expression of VEGFC transcripts are correlated with slow disappearance of blasts during treatment, lower CR rate, reduced overall survival (OS) and event-free survival (EFS), and inferior disease outcomes [49]. Here, VEGFC is linked to acute myeloid leukemia.